Last reviewed · How we verify
Herpes Zoster Vaccine 1437173A — Competitive Intelligence Brief
phase 2
Biologic
Live · refreshed every 30 min
Target snapshot
Herpes Zoster Vaccine 1437173A (Herpes Zoster Vaccine 1437173A) — GlaxoSmithKline.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Herpes Zoster Vaccine 1437173A TARGET | Herpes Zoster Vaccine 1437173A | GlaxoSmithKline | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Herpes Zoster Vaccine 1437173A CI watch — RSS
- Herpes Zoster Vaccine 1437173A CI watch — Atom
- Herpes Zoster Vaccine 1437173A CI watch — JSON
- Herpes Zoster Vaccine 1437173A alone — RSS
Cite this brief
Drug Landscape (2026). Herpes Zoster Vaccine 1437173A — Competitive Intelligence Brief. https://druglandscape.com/ci/herpes-zoster-vaccine-1437173a. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab